Fundraising Fox
🦊/Companies
Sign in

Exobiosphere

Founded 2024 · 27 employees on LinkedIn · 6 known investors

Find your way into Exobiosphere

403 people in our graph share verified history with the Exobiosphere team — schools, employers, funds. One of them is your warm intro.

Collin Wallaceunlockedknows Kyle Acierno · together at Tsinghua University (overlapped)
×2knows the team · via The Explorers Club
knows the team · via Tsinghua University
knows the team · via Universidade de Aveiro
×4knows the team · via Simon Fraser University
×3knows the team · via International Space University

Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.

BiotechDeep TechSpace Tech

Founders & leadership

Exobiosphere was founded in 2024 by Kyle Acierno, Bruno Santos, and Olivia Borgue.

KAKyle Acierno
Kyle AciernoinCo-Founder & Chief Executive OfficerHe has over a decade of experience in commercial space exploration, holds a bachelor's degree in International Security and a master's degree in Space Studies, and has held leadership roles across Asia, North America, and Europe.
BSBruno Santos
Bruno SantosinCo-Founder & Director of R&DBruno Santos is Co-Founder and Director of R&D at Exobiosphere, where he oversees the development of space-based testing platforms for pharmaceutical and biotech research. He has background expertise in pre-clinical studies, drug development, and lab automation.
OBOlivia Borgue
Olivia BorgueinCo-Founder & Director of EngineeringShe has over a decade of engineering experience in spacecraft systems, nuclear R&D, and Antarctic operations, previously leading microgravity hardware development at Yuri and OffWorld, and holds a PhD in space systems engineering.

Investors · 6

Expansion VenturesParisvia Ted Elvhage · inferred
Expon CapitalLuxembourg · $550K – $1.6M

Also in the syndicate · 4

BoryungCedars-Sinai Technology VenturesSpace DataSpace Data Inc.

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Exobiosphere Receives One Million Euros in Government Funding for Space Biotech Platform | Startbasestartbase.com · Aug 2026Exobiosphere Secures €1 Million Grant from Luxembourg’s JEI — Exobiosphereexobiosphere.com · Aug 2026Luxembourg’s space BioTech Exobiosphere secures €1 million to find “cures from space”eu-startups.com · Aug 2026Exobiosphere joins the Cedars Sinai Accelerator+ program with a $1.4M Seed Extension investment — Exobiosphereexobiosphere.com · Nov 2025Exobiosphere to Install Orbital High-Throughput Screening Device on Haven-1 Lab — Exobiosphereexobiosphere.com · Apr 2025Luxembourg’s Exobiosphere raises €2M to accelerate drug discovery in space; here’s why and how - Silicon Canalssiliconcanals.com · Apr 2025Exobiosphere raises €2M seed round to bring drug discovery to space — Exobiosphereexobiosphere.com · Apr 2025

Frequently asked questions

What does Exobiosphere do?
Exobiosphere is building a standardized space-based high-throughput testing platform that lets pharma and biotech partners run automated experiments in orbit, using microgravity combined with lab automation and bioinformatics to create more physiologically relevant 3D biology models. The company aims to accelerate drug discovery and make space a routine part of the biomedical R&D pipeline.
Who founded Exobiosphere?
Exobiosphere was founded by Kyle Acierno, Bruno Santos, Olivia Borgue in 2024.
Who are Exobiosphere's investors?
Exobiosphere's investors include Expansion Ventures, Expon Capital.